4Clinical and Laboratory Standards Institute.Approved Standard M100-S17.Performance Standards for Antimicrobial Susceptibility Testing 2008,Clinical and laboratory standards institute.
5Fernande-Cuenca F,Martinez-Martinez L,Conejo MC,et al.Relationship between beta-lactamase production,outer membrance protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii[J].J Antimicrob Chemother,2003,51(3):565-574.
6Denton M,Kerr KG.Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia[J].Clin Microbiol Reviews,1998,11(1):57-80.
7Weiss K,Restieri C,Carolis ED,et al.Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia[J].J Antimicrob Chemother.2000.45(3):363-365.
